MTOR and cancer: The PI3K-Akt-mTOR signalling pathway is among the most common intracellular signalling pathways that are often abnormally activated in many human cancers and participate in different biological effects, such as cell cycle progression and cell proliferation (Wong et al., 2010; Shimizu et al., 2012).